Case Studies > Life Science

Refine Results

Functions

Industries

Private Equity & Venture Capital (1)

Project Types

Interim Executives (2)
Operations & Performance (10)
Organizational Design & Effectiveness (5)
Project Management (16)
Strategy & Planning (27)
Transformations (8)

53 Case Studies Found:

A Risk Management Expert for Medical Device and Combination Products

An F200 pharma company needed an experienced principal risk management engineer to assess current processes and develop improvements to mitigate risk during development and manufacturing of medical devices and combination products. The engagement would also include continued advancement in risk assessment methods and tools, as…

Developing Compelling Global Health Policy Narratives and Supporting Evidence

As a part of its global therapeutic area (TA) health policy initiatives, a leading biopharma company needed a new and improved narrative and evidence deck to impress upon policymakers and other critical stakeholders the importance of timely diagnosis and treatment of a specific disease. The…

Project Management Lead for Medical Evidence, Research, and Innovation Team

An F500 biotech company wanted to engage a consultant to work with its medical evidence, research, and innovation team to create and coordinate several projects related to the generation of Real-World Data (RWD). BTG delivered a former Accenture Managing Director with deep experience developing RWD…

Managing Patient / HCP Promotions Process in Biopharma

The U.S. patient access team at an F200 biopharma leader was seeking a strong project manager who would support their market access and marketing teams with patient / HCPs promotions. The client was looking for a consultant who had good payer, patient, and policy acumen,…

Digital Health Strategy Refresh

An F200 pharma company wanted to implement next generation digital health technologies, which required a thorough review of the existing strategy across three therapeutic areas and a roadmap for moving forward. Needing to assemble an overview of digital capacity and capabilities as well as market…

A Team of Experts to Improve Pharma Manufacturing Control Strategy

Pursuing growth into personalized medicine and safer, more effective drug therapy, an F200 biopharmaceutical company wanted to improve its cross-functional end-to-end control strategy and tactics for the manufacture of combination products. In an effort to accelerate the workstream development, a director in manufacturing reached out…

Early pipeline market access evaluations

In the midst of a company-wide reorganization, the Cell Therapy Market Access team at an F200 pharmaceutical company needed a value and access expert to support several projects. Looking for strategic input and leadership to help assess the access implications for both early pipeline assets…

Pharmacovigilance and regulatory affairs portfolio support

A global nonprofit was developing new initiatives focused on building pharmacovigilance systems and regulatory capacity in low and middle-income countries (LMICs). As more pharmaceutical products and technologies were being introduced directly into LMIC, and without the same safety checkpoints as high-income countries, the organization sought…

Pricing and contracting oversight for IT transformation

The Global Technology Services Group of an F100 pharmaceutical company wanted to streamline global IT application development and turned to Business Talent Group when they needed support managing baseline spend. Looking for oversight of maintenance contracting and pricing—including pricing template consolidation and analysis—as well as plans…

Digital transformation training curriculum

As part of a large, end-to-end supply chain transformation, a multinational life science company was implementing a new cloud-based procurement system. In order to ensure success, the global procurement team needed to adopt an entirely new way of working. The head of strategic project delivery…

Implementation Planning for F200 Biotech Acquisition

The Director of Product and Portfolio Management at a F200 biopharmaceutical company needed to replace a team of Big Three consultants who had begun working on the integration of a recent acquisition. Looking for three skilled project managers to round out internal resources and keep the integration on track, she turned…

Reorganizing the Global Pharmacovigilance Function

An F200 pharma company was reevaluating the operating model of its global drug safety and pharmacovigilance functions. Looking for help assessing cost, quality, and productivity impact of different resourcing scenarios, the group’s head turned to BTG. We delivered an independent pharmacovigilance organization specialist and former…

Pharmaceutical Target Valuation

The head of M&A at a global pharma company was evaluating an acquisition target based in India. His team had already assessed the company’s core business, but it needed help understanding the valuation of non-core assets in Europe and the U.S. Business Talent Group put…

Preparing a Biopharma Congress Plan

A global biopharma company was preparing to launch two promising treatments in the same therapeutic area. To maximize impact, the head of marketing wanted to develop a comprehensive healthcare provider (HCP) Congress plan that incorporated both therapies. Yet her lean team lacked the bandwidth to…

Oncology Commercial Assessment

The head of commercial development at a global biopharma giant was assessing the outlook for several oncology indications in key Asian markets. The team had already secured secondary research sources, and it had contracted with external agencies to conduct primary research. However, there was no…

Biopharma Due Diligence

A global biopharma company was evaluating an acquisition whose potential indications ranged from gastrointestinal disorders to ophthalmology. With a key leader out on vacation and the deadline for a non-binding term sheet drawing near, the company’s head of Commercial Business Development turned to Business Talent…

Reinventing Consulting

Leaders at this biopharma giant didn’t set out to reinvent the way the company sourced industry experts and management consultants. But after eight years and more than 150 successful projects in functions as diverse as strategy, market access, product launch, lifecycle management, and digital health—across…

Redesigning the Regulatory Submissions Process

The internal consulting group at a Fortune 200 pharmaceutical company was redesigning the organization’s regulatory submission process—and creating an integrated framework to use for planning all submissions. The group had already installed a technology solution to facilitate communication between the company’s headquarters and its individual…

Driving Data Science Adoption

The head of R&D Strategy and Operations at a global pharmaceutical company was establishing an enterprise-wide data science council to ensure the successful adoption of new analytics technologies. Looking for support managing key milestones and creating educational content as he rolled out the new council’s…

Interim Finance Manager

A finance manager at an F100 pharmaceutical company was going on maternity leave, and the company needed a highly experienced temporary replacement to manage compliant revenue accounting processes for their commercial teams as well as execute critical end-of-year projects. Business Talent Group delivered an interim…

Biopharma Product Launch

A global biopharmaceutical company was preparing to launch a promising new rare disease therapy in the UK and Europe. Concerned that the company’s functional leads were too busy managing existing products, senior leadership formed a global commercialization team to drive all launch activities. However, coordinating…

Clinical Process Transformation Program

Executive leaders at an F100 life science company were implementing a multi-year transformational program to boost the speed and efficiency of their global product development function. This would, they knew, be a long-term project with complex, shifting demands. Looking to maximize resources while responding effectively…

Interim Head of HR at a Rapid-Growth Pharma Company

The operating partner at a global Private Equity firm was working on the carve-out acquisition of an undervalued pharmaceutical business. He knew it would take time to find the right lead for the new company’s Human Resources department, so he turned to Business Talent Group…

Neuroscience Therapeutic Area Strategy

A VP at a major biopharma company was interested in defining his strategy in the neuroscience space. Looking for a more targeted way to assess the opportunity than big consulting firms could provide, he turned to BTG. We deployed two ex-McKinsey life science strategists to…

Early-Stage Marketing Support

A major pharmaceutical company was pursuing multiple indications for a groundbreaking oncology therapy. Struggling to keep up with the work, the global marketing team concluded it would need to rethink its resourcing strategy—and turned to Business Talent Group. Over the course of the next year,…

Enterprise-Wide Project Management

Business Talent Group supports a leading biopharma company with on-demand project managers to accelerate the execution of new product launches, drug repositioning initiatives, and therapeutic area marketing strategies. These consultants ensure that all deliverables are developed, approved, and executed on time, from branding strategies and…

Market Access Sales Training and Support

The pharmaceutical reimbursement landscape has grown increasingly complex and—thanks to an intensifying focus on improving clinical outcomes—increasingly competitive. Reimbursement was once a formality that followed regulatory approval. Now, it’s forcing life science companies to rethink their market access strategies and reorganize the way they develop…

Market Access Innovations: Pharmaceutical Affordability

Affordability is a major concern in health and life science—and not just in the U.S. In 2018, total prescription drug expenditure in the U.S. is expected to top $520 billion; 52% of Americans say bringing down the price of prescription drugs should be a “top…

Commercializing A Breakthrough Medicine

A major biopharmaceutical company had developed a breakthrough medication that stood to dramatically disrupt the market for its therapeutic area. Expected to be approved by the FDA in the next year or two, this new drug had the potential to bring billions of dollars upon…

Improving A Business Plan

The director of one of a life science company’s business units was hoping to reduce the size and complexity of his division’s business plan. As the initiative’s deadline approached, it became clear that he needed help gathering, synthesizing, and then paring down tactics and budgets…

Preparing For a Major R&D Transformation

The head of R&D at a F500 pharmaceutical company was preparing for a major transformation aimed at using new technologies to drive more efficient decisions throughout the drug development process. McKinsey was helping her develop top-line strategies. But the project had already been organized into…

Product Pipeline Assessment

A global life science company needed needed a fresh look at the competitiveness of its US portfolio with respect to current products and the five-year pipeline. Lacking the internal resources to complete the project—and hoping to avoid the heavy footprint of a traditional consulting firm—the…

Strategic Project Management

In an effort to overhaul its quality assessment system, a F500 life science company had assembled a working group of high-level execs and experts. Without a Project Management Office to guide them, however, the project’s leaders were worried about their ability to stay organized. They…

Overseeing a Big Relocation

A global Life Science company was relocating after a split. The head of business operations needed help coordinating 12 different workstreams related to the move, including office stacking, food service, IT, infrastructure, and more… at 4 different offices across the country. Independent consultants excel on…

Hematology Market Planning

The dynamic culture at this biotech company creates opportunities for employees as they rotate responsibilities and projects. It also creates opportunities for the external consultants the company relies on to supplement internal teams and minimize disruptions to productivity. In one recent example, the company’s Market…

Biopharma Product Launch Support

As the launch date for a major new drug drew near, this global biopharma company found its team overstretched and under-resourced. Rather than postpone the launch, they contacted Business Talent Group to get the project back on track. Our McKinsey-trained product launch expert supported the…

Reprioritizing Pharma Projects

The Project Management Office at a global pharma company’s North American division was struggling to keep up with the hundreds of initiatives it coordinated across the business. Hoping to restructure reporting practices and reprioritize the work, the head of corporate strategy turned to Business Talent…

Centralizing Operational Excellence

A global pharmaceutical company’s internal consulting group took responsibility for enterprise-wide transformation initiatives that had previously been handled by external firms. The group’s VP knew he could reduce consulting spend and drive change at the company, but he was struggling to manage an uneven and…

Implementing Range-Based Forecasting

A F500 pharma company’s pricing group was moving from point to range based forecasting. As the team began to update their models, they realized they needed an expert to validate plans and processes. Previously, the team relied on a complicated Excel spreadsheet to predict annual…

Addressing Complexity in R&D Contracting

As a global pharma company grew, so too did the complexity of its R&D contracting needs. Demand from R&D was straining current processes, and internal teams were struggling to avoid delays while managing multiple stakeholders and fulfilling all process requirements. Internal work had identified several…

Indication Prioritization

The VP of Global Marketing at an F200 pharma company was reviewing a promising drug about to enter Phase II of R&D. The company’s lean team had already completed a broad indication assessment, but they needed help preparing a more detailed opportunity assessment that leveraged…

Accelerating an Oncology Drug Launch

An F300 pharma company was preparing to launch a new oncology drug. But its understaffed pricing and market access group was struggling to create global access plans and strategies. Expecting accelerated regulatory approvals in the US and Europe, the company’s Director of Global Pricing turned…

Assessing a Digital Wellness App

The VP of Business Development at an F200 health company was struggling with pricing pressures following the commoditization of a key product. The strategy leader for the product’s division wanted to explore adjacent growth opportunities. In particular, he wondered if a self-management platform for patients…

Accelerating a Go-to-Market Strategy

The head of global marketing at a Fortune 100 life science company faced gaps in his team’s capabilities after an enterprise-wide reorganization. As he prepared to re-launch a product within its core clinical market, it became clear that he couldn’t wait to make full-time hires…

Oncology Market Access Support

The lean market access group at a global pharma company was preparing to launch a recently acquired pipeline oncology asset. Yet they were struggling to coordinate US payer marketing activities. Looking for additional expertise in oncology market access, they turned to Business Talent Group. Our…

IDN Engagement Strategies

A biopharma company was building a value-based partnership program to deepen customer engagement and ensure closer alignment with patient strategies. The head of value marketing reached out to Business Talent Group for help creating an engagement strategy for integrated delivery networks (IDNs) for one of…

Assessing an Acquisition’s Market Access Potential

A multi-million-dollar pharmaceutical company was in talks to acquire an orphan drug manufacturer with a pipeline asset that was about to launch in Europe. The company’s corporate development team was focused on the deal’s financials, but they lacked the expertise to assess the access potential…

Digital Health Data Strategy

The director of digital health at an F200 pharma company was developing a new patient adherence device. The goal: to use real-time usage data to improve care and enhance the patient experience. Yet the team was having difficulty determining what information to collect—and developing a…

Multi-channel Marketing

The mature brands division at a F200 pharma company was struggling to understand how the digital marketing approvals process varied across Europe. The marketing group was too busy creating plans and materials to assemble a comprehensive view. The head of digital marketing turned to Business…

Building a Direct-to-Consumer Sales Channel

The transformation group at a F200 pharma company was piloting a direct-to-consumer channel for a dozen of its mature brands. The strategy was set. To keep up with an aggressive execution schedule, however, the group turned to Business Talent Group for program management support. Business…

Reassessing the Generics Strategy

The head of strategy at an animal health company was facilitating a global strategy refresh. She knew it would be critical to reassess the company’s strategic focus for generics, but the GM of the relevant business unit was too busy managing two global businesses to…

Biopharma Marketing Support

The European-based internal consulting group at a global biopharma giant was building out its U.S. team. Hoping to respond quickly to the needs of his internal stakeholders, the group’s leader turned to Business Talent Group to increase capacity without waiting on full-time hires. We supported…

Oncology Assessment for Biosimilar In-licensing

The head of marketing for a biopharma company’s biosimilars business unit was struggling to size two oncology in-licensing opportunities in the U.S. and Europe. Looking for an informed assessment—and a broader picture of biosimilar developments in the oncology market—she turned to Business Talent Group. Our…